The Head and Neck Surgery team represented UNC-Chapel Hill at the 11th Annual International Conference on Head and Neck Cancer with oral and poster presentations, and a second place winning poster by Jason Tasoulas.
The Head and Neck Surgery team represented UNC-Chapel Hill at the 11th Annual International Conference on Head and Neck Cancer with nine oral and poster presentations and a second place winning poster.
The following are presentations and posters showed by UNC Otolaryngology Head and Neck Surgeons:
- The role of tumor HPV status in survival and treatment response of patients with squamous cell carcinoma of the hypopharynx; authored by Tasoulas and Hackman, oral presentation
- Intra-tumoral copy number variant heterogeneity is common in HPV-positive head and neck squamous cell carcinoma tumors and cell lines; authored by Tasoulas and Schrank, oral presentation
- 5-azacytidine promotes immune recognition and T cell infiltration in HPV-positive head and neck squamous cell carcinoma patients; authored by Tasoulas and Yarbrough/Isaeva, poster
- The role of immunotherapy in salivary gland cancer: a systematic review; authored by Kim and Sullivan, oral presentation
- Molecular-based confirmation of the neck imaging reporting and data system (NI-RADS) in the treatment of HPV + oropharynx cancer; authored by Stepp and Hackman
- The International Status of Social Determinants of Health Reporting in Major Head and Neck Cancer Databases; authored by Farzal and Hackman, oral presentation
- Prognostic Stratification of HPV Associated Head and Neck Squamous Cell Cancer; authored by Kim and Yarbrough/Isaeva, poster
- Free flap reconstruction to address chronic, non-healing otologic wounds: a case series, authored by Cheever and Blumberg, poster
- Outcomes of anterolateral thigh flap, radial forearm flap, and pectoralis major flap in total laryngectomy: a retrospective review; authored by Cheever and Blumberg, poster
Jason Tasoulas and his team won second place for their poster, 5-azacytidine promotes immune recognition and T cell infiltration in HPV-positive head and neck squamous cell carcinoma patients.